Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422329 · ClinicalTrials.gov registry record · NA
Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention
A NA study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
NCT02422329: Completed NA study, sponsored by M.D. Anderson Cancer Center.
NCT02422329 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 59 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02422329, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
Study Summary
The goal of this research study is to learn how patients' think about constipation before and after receiving education about the subject.
Primary Outcome
Primary objective is to examine effect of educational intervention on the patient-reported perception of constipation (PRC, by a 0-10 numeric rating score) among advanced cancer patients.
Interventions
- BEHAVIORAL Questionnaires
- BEHAVIORAL Video
- BEHAVIORAL Fact Sheet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2015-04-30 |
| Est. Completion | 2018-03-07 |
| Phase | NA |
What the finished NCT02422329 record still lists
NCT02422329 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 3 interventions - of which Questionnaires is the first listed.
NCT02422329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02422329 about?
NCT02422329 is a clinical study titled "Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational Intervention". The goal of this research study is to learn how patients' think about constipation before and after receiving education about the subject.
What is the current status of trial NCT02422329?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2015-04-30. Estimated completion is 2018-03-07.
What interventions are being tested in trial NCT02422329?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Video (BEHAVIORAL), Fact Sheet (BEHAVIORAL).
Who is sponsoring clinical trial NCT02422329?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02422329's enrollment target sits among peer trials
59 1256th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI